BLEOMYCIN THERAPY FOR CYSTIC HYGROMA

被引：113

作者：

ORFORD, J ^{[1
]}

BARKER, A ^{[1
]}

THONELL, S ^{[1
]}

KING, P ^{[1
]}

MURPHY, J ^{[1
]}

机构：

[1] PRINCESS MARGARET HOSP CHILDREN,DIV SURG,SUBIACO,WA 6008,AUSTRALIA

来源：

JOURNAL OF PEDIATRIC SURGERY | 1995年 / 30卷 / 09期

关键词：

CYSTIC HYGROMA; LYMPHANGIOMA; SCLEROSING THERAPY; BLEOMYCIN;

D O I：

10.1016/0022-3468(95)90485-9

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Intralesional bleomycin injection was used as sclerosant therapy for sixteen patients with cystic hygroma. An excellent (complete clinical resolution) response was obtained in seven (44%) patients, a good (> 50% response) result in seven (44%), and a poor or no response in two (12%). Minor transient side effects (fever, vomiting, cellulitis, skin discoloration) were seen in six patients, and there were no serious side effects. The results suggest that bleomycin intralesional sclerosant is effective therapy for cystic hygroma, with response rates comparable to those of surgical removal, but with the advantage of avoiding inadvertent nerve damage and scarring. Copyright (C) 1995 by W.B. Saunders Company.

引用

页码：1282 / 1287

页数：6

共 9 条

[1]

OGITA S, 1987, BRIT J SURG, V74, P690

[2]

OGITA S, 1993, ANN M BRIT ASS PAEDI

[3] INJECTION OF BLEOMYCIN AS A PRIMARY THERAPY OF CYSTIC LYMPHANGIOMA [J].

OKADA, A ;

KUBOTA, A ;

FUKUZAWA, M ;

IMURA, K ;

KAMATA, S .

JOURNAL OF PEDIATRIC SURGERY, 1992, 27 (04) :440-443

[4]

Ravitch M, 1993, PAEDIATRIC SURGERY, P533

[5]

TANAKA K, 1990, PEDIATR SURG INT, V5, P270

[6]

TANIGAWA N, 1987, CANCER-AM CANCER SOC, V60, P741, DOI 10.1002/1097-0142(19870815)60:4<741::AID-CNCR2820600406>3.0.CO

[7]

2-2

[8]

1991, GOODMAN GILMANS PHAR, P1246

[9]

1990, LANCET, V335, P511

← 1 →